A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/38 (2006.01) A61K 31/19 (2006.01) A61K 31/34 (2006.01)
Patent
CA 2155828
Process of treatment of mammals, including humans to treat diseases or conditions of the type which are normally treated with retinoid-like is disclosed, with pharmaceutical compositions containing an active compound which is a selective agonist of the RXR retinoid receptor sites in preference to the RAR retinoid receptor sites. A compound is defined to be a selective agonist of the RXR receptor site if the compound is at least approximately ten times more effective as an agonist in the RXR receptor sites than in the RAR receptor sites.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Therapeutic use of compounds having selective agonist-like... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic use of compounds having selective agonist-like..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of compounds having selective agonist-like... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1791790